<DOC>
	<DOC>NCT00287534</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy and tolerability of 3 years treatment with anastrozole after a prior 2 years' treatment with tamoxifen versus 5 years treatment with tamoxifen in postmenopausal women with early breast cancer</brief_summary>
	<brief_title>Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Signed informed consent, Postmenopausal women â‰¤75 years, histologically confirmed invasive breast carcinoma (no distant metastases), positive hormone receptor status, continuous 2year adjuvant tamoxifen therapy 20 mg/30 mg with 4 weeks after primary surgery menopause status maintained by medication, preoperative chemotherapy or hormone therapy or radiation therapy, relapse or second carcinoma or previous cancerous disease, breast carcinoma in situ, simultaneous carcinoma of the opposite side or secondary breast, 10 or more tumourinfiltrated lymph nodes. serious accompanying diseases</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Early Breast Cancer</keyword>
</DOC>